Status:
UNKNOWN
The Effect of Dexmedetomidine on Postoperative Quality of Recovery
Lead Sponsor:
Kyungmi Kim
Conditions:
The Effect of Dexmedetomidine on Postoperative Quality of Recovery
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
Dexmedetomidine is a selective a2-agonist and a sedative with anti-inflammatory,analgesic, and antiemetic effects, and its use for procedural sedation during endoscopy or ablation for atrial fibrillat...
Eligibility Criteria
Inclusion
- The patients who undergo elective cholecystectomy
- Adults (20\~75 years old)
- an American Society of Anesthesiologists physical status of I or II
Exclusion
- The patients do not provide written informed consent
- The patients have had allergic response to dexmedetomidine.
- The patients have mood disorder or anxiety disorder.
- The patients are not able to express their emotions.
- The pregnant women
Key Trial Info
Start Date :
May 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03468062
Start Date
May 9 2018
End Date
August 31 2019
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gil Medical Center, Gachon University College of Medicine
Incheon, South Korea, 21556